Foreign Collusion, Naked Shorting (Counterfeiting) & Money Laundering — All Illicit Wealth
Inovio to expand manufacturing of COVID-19 vaccine candidate with new CEPI grant
Ciara Linnane
MarketWatch, 30 April 2020
Inovio Pharmaceuticals Inc. INO, -14.30% said Thursday it has received another grant from the Coalition for Epidemic Preparedness Innovations, or CEPI, an Oslo-based organization, to help it expend manufacturing of its COVID-19 vaccine candidate.
Comment: This is how they force people to sell. Many people buy on margin and as it goes lower they need more money.
Joshua Mitts, Ph.D is an Associate Professor of Law at Columbia Law School. Joshua Mitts, who joined the faculty in 2017, uses advanced data science for his research on corporate and securities law. His primary focus is on information disclosure in capital markets, consumer financial protection, and related topics in law and finance. Mitts employs empirical methods, including statistical analysis and machine learning, for his research on short-selling, informed trading on cybersecurity breaches, information leakage and hedge-fund activism, insider trading on corporate disclosure, and information transmission in financial markets.
EYES a stock that can help people SEE again is $2 DOWN from $9
Like i said they sold short and now THEY tell everyone they are going to INVEST but all they did was sell at $9 and buy back at $2 making $7 X how many shares naked shorted == MILLIONS of profit
Continue reading “Example: EYES – Helps People See Again, Killed by Naked Short Sellers”
| Date | Open | High | Low | Close* | Adj Close** | Volume |
|---|---|---|---|---|---|---|
| Apr 30, 2020 | 2.1500 | 2.3400 | 2.0600 | 2.2400 | 2.2400 | 1,576,719 |
| Apr 29, 2020 | 2.3800 | 2.4000 | 2.1200 | 2.1800 | 2.1800 | 2,100,600 |
| Apr 28, 2020 | 2.2800 | 2.4500 | 2.2100 | 2.3200 | 2.3200 | 1,741,200 |
| Apr 27, 2020 | 2.1000 | 2.4100 | 1.9100 | 2.3100 | 2.3100 | 3,809,200 |
| Apr 24, 2020 | 2.3400 | 2.3500 | 2.1500 | 2.2600 | 2.2600 | 2,188,200 |
| Apr 23, 2020 | 1.9900 | 2.4000 | 1.8000 | 2.3100 | 2.3100 | 6,828,600 |
| Apr 22, 2020 | 2.6900 | 2.7400 | 2.0300 | 2.1800 | 2.1800 | 14,387,000 |
| Apr 21, 2020 | 2.7300 | 4.1700 | 2.4500 | 2.6750 | 2.6750 | 123,722,000 |
| Apr 20, 2020 | 1.0000 | 1.0700 | 0.9160 | 1.0450 | 1.0450 | 508,600 |
Comment: Do the math: Average sale was $3, now $2 = $50 million in profit in 6 trading days just by selling counterfeit shares.
Jim Cramer fires entire staff after soundboard calls him a stock pumper
Richard Landenstein
TheStonkMarket.com, 29 April 2020
Cramer has faced criticism recently by anonymous finance-focused Twitter accounts with accusations that he is a “shill” who pumps stock prices regardless of the consequences. “I block anyone who suggests I pump stocks. I’m one of the people.” Cramer explained. “It doesn’t matter what I’ve said in the past. It’s only a stock pump if I say it is.
H.C. Wainwright Maintains a Buy Rating on BerGenBio AS (BRRGF)
Christine Brown
SmarterAnalyst, 29 April 2020
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on BerGenBio AS (BRRGF) today and set a price target of NOK66.00. The company’s shares closed last Monday at $1.23.
According to TipRanks.com, Pantginis is a 5-star analyst with an average return of 8.2% and a 41.6% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Lineage Cell Therapeutics, and Iovance Biotherapeutics.
Comment: This company is at risk of collusion between a placement agent and naked short sellers.
How it works:
Wirecard: what KPMG’s report found
The payments group had predicted vindication from a special audit — it did not arrive
Dan McCrum and Olaf Storbeck
Financial Times, 29 April 2020
For months Wirecard had confidently predicted that KPMG would vindicate its accounting and deliver a final riposte to its sceptics. Instead, the publication on Tuesday of a report from the accounting firm caused shares in the Dax 30 company to crash 26 per cent as investors learnt that KPMG’s investigators had faced obstacles in their attempts to verify that large parts of the business were real, and publication of full-year results would be delayed again. The shares fell another 7 per cent on Wednesday.
I think the "Germans" are now embarrassed about $WDI and have been misled at every turn.. Enough is enough Bafin, you have put alot of people at risk, time to act like a Securities Regulator @FD @FelixHoltermann
— Marc Cohodes (@AlderLaneeggs) April 29, 2020
21.2 Million Reasons Aurora Cannabis Is a Terrible Stock
Sean Williams, 28 April 2020
If you thought the stock market has been taken on a wild ride over the past two months, then take a closer look at how marijuana stocks have fared since the beginning of April 2019. Following the first quarter of 2019, which saw numerous pot stocks rocket into the stratosphere, the past 13 months have erased anywhere from 50% to 95% of cannabis stock valuations.
Mind you, the long-term outlook for the legal weed industry is promising. Tens of billions of dollars in sales are conducted in the black market each year, meaning there’s a very real opportunity to move these illicit users to legal channels over time. But in the short run, U.S. pot stocks have been crushed by high tax rates, while Canadian cannabis companies have run into supply bottlenecks and shortages, depending on the province.
Continue reading “Article: 21.2 Million Reasons Aurora Cannabis Is a Terrible Stock”
27 April 2020
Investors who purchased the Company’s securities between February 26, 2016 and March 6, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before June 8, 2020.
RM LAW Announces Class Action Lawsuit Against Bed Bath & Beyond Inc.
27 April 2020
RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Bed Bath & Beyond, Inc. (“Bed Bath & Beyond” or the “Company”) (NASDAQ: BBBY) securities during the period from October 2, 2019 through February 11, 2020, inclusive (the “Class Period”).
Jamie Powell
Financial Times, 18 March 2020
In the past seven days, various bans on short-selling — the practice of betting on a stock falling in price — have come into effect across Italy, France, Belgium, Spain and Greece. The reason? In Italian regulator Consob’s own words: “these measures were made necessary by the strong turbulences triggered in the last days by the Covid-19 pandemic”.
EU rules out permanent naked CDS shorting ban
Nikki Tait
Financial Times, 17 May 2011
Europe’s finance ministers have backed short selling curbs that fall short of a permanent ban on the “naked” shorting of sovereign swaps.
Global Newswire, 27 April 2020
BOSTON, April 27, 2020 (GLOBE NEWSWIRE) — Today, research analyst Citron Research published a report calling Inovio (INO) “The COVID-19 Version of Theranos,” in which Citron slashed its target price for Inovio common stock by 93%.
Dr Left has a $1 target stock is $11 ( you know he shorted at $16-17 and covered already never waiting for his $1 target SHORT AND DISTORT for a quick profit
THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?
